Skip to content
Disclosery

EXANE DERIVATIVES: ORLY position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on ORLY, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 2 ORLY shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 2 shares
    Change vs previous 13F -863 shares

    <0.01% of the 13F portfolio, value $1,263.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 865 shares
    Change vs previous 13F +860 shares

    0.17% of the 13F portfolio, value $592,519.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 5 shares
    Change vs previous 13F -2 shares

    <0.01% of the 13F portfolio, value $3,531.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 7 shares
    Change vs previous 13F +3 shares

    <0.01% of the 13F portfolio, value $4,278.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 4 shares
    Change vs previous 13F 0 shares

    <0.01% of the 13F portfolio, value $2,358.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 4 shares
    Change vs previous 13F 0 shares

    <0.01% of the 13F portfolio, value $2,029.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 4 shares
    Change vs previous 13F 0 shares

    <0.01% of the 13F portfolio, value $1,810.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 4 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $1,844.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).